European Commission’s consultation webinar on vaccine-preventable cancers – RIVER-EU project contributes

Joint webinar to identify synergies addressing vaccination uptake

RIVER-EU project coordinator, Dr Danielle Jansen, joined the European Commission’s stakeholder’s webinar: ‘Commission proposal for a Council Recommendation on vaccine-preventable cancers’, which took place on the 23rd of March 2023. The Commission’s proposal for a Council Recommendation on vaccine-preventable cancers aims to help Member States address vaccine-preventable cancers with a focus on increasing the uptake … Read more

The third RIVER-EU newsletter is out!

2nd RIVER-EU Newsletter

The third RIVER-EU newsletter is out! Among other things, we invite you to read about our progress in the past six months and learn more about the field work from researchers working with the selected underserved communities in Slovakia, Finland, the United Kingdom and the Netherlands.

Extension of HPV vaccination programme to boys in the Netherlands

In the Netherlands, human papillomavirus (HPV) vaccination was introduced in 2010 in the national immunization programme, targeted towards adolescent girls in the year they turned 13 years old. The selected vaccine is bivalent, targeting HPV types 16 and 18. In 2022, the HPV vaccination programme was extended to boys, with the first round of vaccinations held in March and April 2022.

Voices from the field: Studying Slovakia’s marginalised Roma communities

Within the RIVER-EU project, a series of qualitative studies were conducted to explore health system barriers to vaccination in selected underserved communities. In Slovakia, the study described barriers to human papillomavirus (HPV) vaccination among girls from marginalized Roma communities from the perspective of Roma girls, their parents, and professionals involved in HPV vaccination who serve this population.

Working together is demanding, but totally worth it: A researcher’s testimony from working with the marginalised Roma community in Slovakia

Roma are the largest and most disadvantaged ethnic minority in Europe. For centuries, the history of Roma has been marked by intolerance, punitive policies, assimilation and social engineering which has ultimately resulted in the development of marginalized Roma communities.

Launch of JA PERCH brings new opportunities to strengthen HPV vaccine uptake

increase HPV vaccination coverage

The launch of the European Joint Action PartnERship to Contrast HPV (PERCH) took place on 5 December 2022 in Brussels. Led by the Italian Institute of Health (Istituto Superiore di Sanità), the three-year PERCH project shares many parallels with RIVER-EU, and hence offers opportunities to strengthen mutual objectives to improve HPV vaccine uptake in Europe.